Weight Loss & Obesity News & Features
- The Scary Health Risk That Can Sneak Up on GLP-1 Users
February 6, 2026 — Next-gen weight loss medications are powerful – but eating too little can put some patients at serious nutritional risk.
- How the New GLP-1 Weight Loss Pill Compares to the Shot
December 30, 2025 — The Wegovy pill has hit the market, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
- Thinking About 'Microdosing' a Weight Loss Drug? Read This
December 4, 2025 — Microdosing GLP-1 weight loss medications – using very small amounts of the popular and pricey drugs – seems to be everywhere, but a lack of clinical trial data on the practice has some experts concerned about safety.
- Destiny Murtaugh: Rewriting Her Story
Destiny Murtaugh is rewriting the story of weight and reclaiming the term “fat” one post at a time.
- Tips for How to Build a Healthy Body Image
If you are overweight or have obesity, a healthy body image is important. Here’s how body image affects weight loss, plus ways to get a more positive body image.
- Mental Health's Effect on Your Weight
Learn about the link between mental health and obesity, and what you might do about it.
- Obesity: Finding Balance Between Acceptance and Improving Health
In the quest for better health, it helps to find your balance first and to start with goals you can achieve while considering the full picture.
- Dance for Fitness and Health
Dance is for everyone. Find out how dance can improve both physical and mental health and how to get started.
- The Limits of BMI
Body mass index uses your height and weight to estimate your body fat. Here’s what this number can and can’t tell you about your health.
- Ways to Advocate for Yourself in the Medical Space
Self-advocacy can help to ensure you get all you need from your doctor, and it’s especially essential when you’re living with obesity. Learn ways to advocate for yourself with doctors from people who really understand.
- Jessie Diaz-Herrera: Save the Last Dance
Jessie Diaz-Herrera hasn’t allowed weight bias to stop her moves. Learn how she’s “freeing the jiggle” and embracing joy.
- Atypical Anorexia and Recognizing the Signs of an Eating Disorder
What is atypical anorexia, and how does it affect people who don’t fit the stereotype of living with an eating disorder?
- Latoya Shauntay Snell: Running Past Doubts, Fears, and Unseasoned Food
Latoya Snell breaks barriers in running as a “body-neutral” advocate for coloring outside the finish line.
- Understanding Weight Bias and Medical Gaslighting
Weight bias and stigma are common problems in obesity health care and may be having real consequences for your health. Learn how to spot bias and medical gaslighting and advice on how to overcome it.
- Dietary Needs for Different Situations and People
A healthy diet is about more than your weight. It’s about fueling your body to run well throughout all of life’s circumstances.
- Obesity’s Cancer Link Is Worse Than You Think
July 31, 2025 — As new research spotlights the obesity-cancer connection, experts warn we’ve underestimated just how much excess weight – and the complex biology behind it – can fuel the disease.
- The Surprising Link Between Childhood Trauma, Weight Gain, and Obesity
Traumatic experiences can affect how people experience hunger and satiety, how well they metabolize food, and how well their pancreas is functioning. Stress hormones affect our tendency to hold on to calories and put on weight.
- Why BMI Still Won’t Die
July 29, 2025 — More and more doctors and scientists say BMI alone won’t tell you much about health, yet it remains the standard assessment for diagnosing obesity. Here’s why.
- Exploring the Link Between Screen Time, Metabolism, and Obesity
It’s well known that too much screen time may be bad for you. But there is also a strong connection between too much screen time and your metabolism. For adults and children, even small amounts of extra time spent in front of screens can cause weight gain and worsen your health.
- Ozempic: Privilege and Access to GLP-1 Weight Loss Drugs
Weight loss drugs such as Ozempic are hugely popular, but that doesn’t mean they’re accessible. Cost, availability, and socioeconomic disparities mean that people who need them the most may not have access.
- Body Image Issues After Weight Loss
Unexpected body image issues and negative feelings may arise after significant weight loss.
- Weight Loss Drugs Work – but Only if You Do These 3 Things
July 16, 2025 — Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.
- Weird, Wacky Side Effects of Weight Loss
A family doctor and obesity specialist talks about strange side effects that can result from weight loss and what you can do about them.
- FDA Shortage Rules and Compound GLPs
Now that the FDA shortage rules have expired, what’s next for people taking compound GLP-1s? Find out what you can do.
- Why Mounjaro Tops Ozempic for Weight Loss
May 12, 2025 — In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who took semaglutide (Ozempic, Wegovy).
- FDA Issues Warning About Counterfeit Ozempic
April 14, 2025 — The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection — found in the U.S. drug supply chain.
- Can Enjoying Food Help You Lose Weight? Research Says Yes
March 26, 2025 — A new study suggests that restoring the pleasure of eating – not suppressing it – may help people eat more intentionally and avoid falling into patterns, offering a possible new way to treat obesity.
- Is Marriage Making You (or Your Husband) Gain Weight?
March 13, 2025 — A new study says that married men may have triple the risk of obesity, compared to unmarried men, and that marriage seems to increase the likelihood of being overweight in both sexes – by 62% in men and 39% in women.
- Did the Weight Loss Industry Hijack Obesity Treatment?
Medical students spend, on average, just 10 hours on obesity education, according to recent research.
- GLP-1 Drugs Again Linked to Blindness Risk
February 12, 2025 — People with type 2 diabetes taking GLP-1 medicines may experience potentially blinding eye conditions as soon as the day after starting the drugs, and eye doctors are now asking their patients to be vigilant in speaking up about any vision changes while taking them.
- Obesity Stigma Depends on Where You Live
February 7, 2025 — People living in areas where obesity is more common may experience less stigma, which could help reduce some of the social and health consequences of being overweight.
- Medicare to Negotiate Lower Prices for Wegovy and Ozempic
January 17, 2025 — Medicare will negotiate the prices of weight loss drugs Wegovy and Ozempic with drug companies, a move that could create big savings for seniors who take the drugs, the Biden administration announced Friday.
- What Will Be the Next Ozempic?
December 5, 2024 — Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising new drugs like tirzepatide and retatrutide—offering even greater weight-loss potential—could become the “next Ozempic,” though high costs, side effects, and limited access remain significant challenges.
- Wegovy vs. Zepbound: New Data Declares a Winner
December 4, 2024 — People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.
- Weight Loss Drugs Linked to Decreased Alcohol Use
December 2, 2024 — Taking weight loss drugs like Wegovy and Zepbound can help people cut back on what they eat and also on what they drink – including alcohol.
- White House Wants Medicare, Medicaid to Cover GLP-1 Drugs
November 26, 2024 — In its announcement, the Biden administration called anti-obesity medicines “life-saving drugs,” noting that they can also prevent diabetes.
- Why You’re Probably Eligible for Ozempic or Wegovy
November 19, 2024 — More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.
- Yes, There Is a Secret Formula for Weight Loss. This Is It
November 19, 2024 — The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.
- New Guidance for Patients Taking GLP-1 Drugs Before Surgery
November 12, 2024 — As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.
- New FDA Warning Added to Popular Weight Loss Drugs
November 6, 2024 — Labels for drugs like Mounjaro, Ozempic, and Saxenda now warn against aspiration risk during surgery.
- Weight Loss Drugs May Be a New Alternative to Knee Replacements
October 31, 2024 — A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.
- 6 Helpful Exercise Modifications to Lower Your Injury Risk
See quick ways to make planks, squats, bridges, push-ups, jumping jacks, and ab exercises easier to do if you have obesity.
- When Compound Pharmacies Make GLP-1s
Compounding pharmacies can make versions of semaglutide (Wegovy) and tirzepatide (Zepbound). Here’s what to look out for.
- Alarming Rise in Severe Obesity Among U.S. Adults
September 24, 2024 — A new CDC report says severe obesity is becoming more common in the U.S. Nearly 1 in 10 adults have severe obesity, and women are more likely than men to have the health condition. Yet from 2013 to 2023, the overall obesity rate held relatively steady around 40%.
- Considering Zepbound in Vials? Here Are Some Starter Tips
September 16, 2024 — The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole new set of people will be learning the sometimes-intimidating skill.
- Obesity Rates Exceed 35% in Nearly Half of U.S. States
September 13, 2024 — Obesity remains a significant health issue in the United States, even as weight loss drugs are getting more popular, according to new data from the CDC.
- How Microplastics May Trigger Weight Gain
September 5, 2024 — Microplastics, found in food, beauty products, and in the air, may add to weight gain by mimicking hormones like cortisol, which can disrupt metabolism and increase obesity risk.
- Vials of Weight Loss Drug Zepbound See Major Price Cut
August 27, 2024 — The maker of the weight loss drug Zepbound is offering the drug at a reduced price for people willing to buy it directly from the company in vials, rather than auto-injector pens.
- Weight Loss Drug Zepbound Significantly Cuts Diabetes Risk
August 20, 2024 — The weight loss and diabetes drug tirzepatide, sold under the brand name Zepbound, was highly effective at reducing the risk of progressing from prediabetes to the more serious condition of type 2 diabetes, according to an early look at study results released Tuesday by drugmaker Eli Lilly.